Wave Life Sciences

About:

Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases

Website: http://wavelifesciences.com

Twitter/X: wavelifesci

Top Investors: Fidelity, RA Capital Management, Cormorant Asset Management, Foresite Capital, Teva Pharmaceuticals

Description:

Wave Life Sciences (Nasdaq: WVE) is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company’s proprietary discovery and drug development platform that enables the precise design, optimization, and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. To find out more, please visit www.wavelifesciences.com and follow Wave on Twitter @WaveLifeSci.

Total Funding Amount:

$867M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2012-01-01

Contact Email:

info(AT)wavelifesci.com

Founders:

Greg Verdine, Takeshi Wada

Number of Employees:

251-500

Last Funding Date:

2024-09-24

IPO Status:

Public

© 2025 bioDAO.ai